Emergent BioSolutions Inc
F:ER4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Emergent BioSolutions Inc
F:ER4
|
US |
Wall St Price Targets
ER4 Price Targets Summary
Emergent BioSolutions Inc
According to Wall Street analysts, the average 1-year price target for ER4 is 11.98 EUR with a low forecast of 11.862 EUR and a high forecast of 12.332 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ER4's stock price target?
Price Target
11.98
EUR
According to Wall Street analysts, the average 1-year price target for ER4 is 11.98 EUR with a low forecast of 11.862 EUR and a high forecast of 12.332 EUR.
What is the Revenue forecast for Emergent BioSolutions Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 7 years is 4%.
What is the Gross Profit forecast for Emergent BioSolutions Inc?
Projected CAGR
-9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 1 year is -9%.
What is the Operating Income forecast for Emergent BioSolutions Inc?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 7 years is 17%.
What is the Net Income forecast for Emergent BioSolutions Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 1 year is 4%.
